KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Times Interest Earned (2016 - 2023)

Supernus Pharmaceuticals has reported Times Interest Earned over the past 13 years, most recently at -$19.33 for Q2 2023.

  • Quarterly Times Interest Earned fell 408.31% to -$19.33 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was -$14.94 through Mar 2024, down 300.91% year-over-year, with the annual reading at -$2.18 for FY2023, 133.44% down from the prior year.
  • Times Interest Earned was -$19.33 for Q2 2023 at Supernus Pharmaceuticals, down from $3.44 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $21.54 in Q4 2022 and troughed at -$19.33 in Q2 2023.
  • The 5-year median for Times Interest Earned is $5.87 (2021), against an average of $4.58.
  • Year-over-year, Times Interest Earned surged 1996.02% in 2022 and then tumbled 408.31% in 2023.
  • A 5-year view of Times Interest Earned shows it stood at $7.07 in 2019, then decreased by 0.17% to $7.05 in 2020, then tumbled by 85.43% to $1.03 in 2021, then surged by 1996.02% to $21.54 in 2022, then plummeted by 189.73% to -$19.33 in 2023.
  • Per Business Quant, the three most recent readings for SUPN's Times Interest Earned are -$19.33 (Q2 2023), $3.44 (Q1 2023), and $21.54 (Q4 2022).